| RNF145 |
Q96MT1
|
ring finger protein 145
|
|
0.98 |
1.000 |
0.038 |
| ELOA-AS1 |
|
ELOA antisense RNA 1
|
|
|
1.000 |
0.038 |
| LINC01714 |
|
long intergenic non-protein coding RNA 1714
|
|
|
1.000 |
0.038 |
| MIR320B1 |
|
microRNA 320b-1
|
|
|
1.000 |
0.038 |
| ZNF816-ZNF321P |
Q8N8H1
|
ZNF816-ZNF321P readthrough
|
|
|
1.000 |
0.038 |
| MIR6731 |
|
microRNA 6731
|
|
|
1.000 |
0.038 |
| LINC01932 |
|
long intergenic non-protein coding RNA 1932
|
|
|
1.000 |
0.038 |
| PSORS8 |
|
psoriasis susceptibility 8
|
|
|
1.000 |
0.038 |
| UBBP4 |
|
ubiquitin B pseudogene 4
|
|
3.6E-06 |
1.000 |
0.038 |
| PNISR |
Q8TF01
|
PNN interacting serine and arginine rich protein
|
|
1.00 |
1.000 |
0.038 |
| TCAIM |
Q8N3R3
|
T cell activation inhibitor, mitochondrial
|
|
2.2E-05 |
1.000 |
0.038 |
| TRAJ23 |
|
T cell receptor alpha joining 23
|
|
|
1.000 |
0.038 |
| LINC02693 |
A8MQB3
|
long intergenic non-protein coding RNA 2693
|
|
0.11 |
1.000 |
0.038 |
| PSORS9 |
|
psoriasis susceptibility 9
|
|
|
1.000 |
0.038 |
| MSX2P1 |
|
msh homeobox 2 pseudogene 1
|
|
|
1.000 |
0.038 |
| PRR9 |
Q5T870
|
proline rich 9
|
|
3.2E-06 |
1.000 |
0.038 |
| PSORS7 |
|
psoriasis susceptibility 7
|
|
|
1.000 |
0.038 |
| TRGV5 |
A0A0B4J1U4
|
T cell receptor gamma variable 5
|
|
|
1.000 |
0.038 |
| PSORS3 |
|
psoriasis susceptibility 3
|
|
|
1.000 |
0.038 |
| ZC3H12C |
Q9C0D7
|
zinc finger CCCH-type containing 12C
|
Nucleic acid binding
|
1.00 |
0.931 |
0.038 |
| BAIAP3 |
O94812
|
BAI1 associated protein 3
|
|
4.4E-32 |
0.931 |
0.077 |
| C10orf99 |
Q6UWK7
|
chromosome 10 open reading frame 99
|
|
0.21 |
0.931 |
0.038 |
| TXK |
P42681
|
TXK tyrosine kinase
|
Kinase
|
8.6E-09 |
0.931 |
0.192 |
| PWP1 |
Q13610
|
PWP1 homolog, endonuclein
|
Transcription factor
|
2.0E-12 |
0.931 |
0.077 |
| HCP5B |
|
HLA complex P5B
|
|
|
0.931 |
0.115 |